Dr. Pamela Tenaerts - 27 May 2021 Form 4 Insider Report for TRxADE HEALTH, INC (SCNX)

Reporting relationship: Former Director
Issuer ticker: SCNX
Reported as of: 27 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2021, 16:45:55 UTC
Source filing: View source filing
Reporting owner signature: /s/ Dr. Pamela Tenaerts

Key filing fact

Dr. Pamela Tenaerts filed Form 4 for TRxADE HEALTH, INC (SCNX) on 02 Jun 2021.

Key facts

This page summarizes Dr. Pamela Tenaerts's Form 4 filing for TRxADE HEALTH, INC (SCNX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jun 2021, 16:45.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDS transaction

Common stock

Disposed to Issuer

Transaction value: $0
Shares: -8,041
Change %: -43%
Price: $0.000000
Shares after: 10,867
Date: 27 May 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Dr. Pamela Tenaerts is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The shares were forfeited back to the Issuer as the reporting person discontinued service to the Issuer as of May 27, 2021, due to the vesting conditions pertaining to the award not having been achieved. Exempt under Rule 16b-3(e).